Franklin Resources Inc Bellus Health Inc. Transaction History

Franklin Resources Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$8.22 - $10.76 $8,976 - $11,749	-1,092 Reduced 0.06%	1,729,081 $14.2 Million
Q2 2022 Aug 11, 2022	BUY	$6.46 - $10.02 $7,177 - $11,132	1,111 Added 0.06%	1,730,173 $16 Million
Q1 2022 May 13, 2022	BUY	$5.56 - $7.99 $4.05 Million - $5.82 Million	729,033 Added 72.9%	1,729,062 $11.9 Million
Q4 2021 Feb 11, 2022	BUY	$5.26 - $8.3 $5.26 Million - $8.3 Million	1,000,029 New	1,000,029 $8.05 Million

128K

Ticker BLU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,793,000
Description
BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. Th...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.